TRIM29 also plays a pro-tumorigenic role through JAK2/STAT3 signaling, induced epithelial to mesenchymal transition (EMT) via the Wnt/β-catenin signaling pathway, and CD44 expression in CRC (41, 42). This evidence concerns the gene TRIM29 and colorectal carcinoma.